News

Filter

Current filters:

None

64 to 73 of 97511 results

Novartis’ Cosentyx gets third approval, now in Europe

19-01-2015

The European Commission (EC) has approved Swiss pharma giant Novartis’ Cosentyx (secukinumab, formerly…

BiotechnologyCosentyxDermatologicalsEuropeNovartisRegulation

Novo Nordisk chooses Switzerland as first country to launch Xultophy

Novo Nordisk chooses Switzerland as first country to launch Xultophy

19-01-2015

Danish diabetes care giant Novo Nordisk has launched Xultophy (IDegLira) for people with type 2 diabetes…

DiabetesMarkets & MarketingNovo NordiskPharmaceuticalSwitzerlandXultophy

Gilead to appeal Indian Patent Office rejection of Sovaldi patent application

Gilead to appeal Indian Patent Office rejection of Sovaldi patent application

19-01-2015

US biotech major Gilead Sciences is to appeal a recent decision by India’s Patent Office to reject…

BiotechnologyGileadIndiaNephrology and HepatologyPatents & Trade marksSovaldi

Supernus sues Par for Trokendi XR patents infringement

19-01-2015

US drugmaker Supernus Pharmaceuticals says it has sued privately-held generics firm Par Pharmaceutical…

GenericsLegalNeurologicalPar PharmaceuticalsPatentsSupernus PharmaceuticalsTrokendi XRUSA

C4X Discovery enters into new research agreement with Evotec AG for treating addiction

C4X Discovery enters into new research agreement with Evotec AG for treating addiction

19-01-2015

UK-based C4X Discovery Holdings has entered into a research agreement with drug discovery alliance Evotec.

BiotechnologyC4X DiscoveryEvotec AGLicensingNeurologicalUK

Janssen among groups in Innovative Medicines Initiative consortia to accelerate Ebola program

Janssen among groups in Innovative Medicines Initiative consortia to accelerate Ebola program

19-01-2015

US health care giant Johnson & Johnson’s Europe-based subsidiary has formed consortia with several…

Anti-viralsEuropeJanssenPharmaceuticalResearchVaccines

The first Sabin IPV approved by China FDA

19-01-2015

The China Food and Drug Administration (CFDA) on January 14 approved the production of the first inactivated…

ChinaPharmaceuticalProductionRegulationVaccines

UCB signs up to $480 million global collaboration with Neuropore on PD

18-01-2015

Neuropore Therapies, a wholly-owned US subsidiary of Austria’s Ever Neuro Pharma, has entered into…

Ever Neuro PharmaGlobalLicensingNeurologicalNeuropore TherapiesNPT200-11PharmaceuticalResearchUCB

64 to 73 of 97511 results

Back to top